BioCardia Statistics
Total Valuation
BioCardia has a market cap or net worth of $5.30 million. The enterprise value is $5.58 million.
| Market Cap | 5.30M |
| Enterprise Value | 5.58M |
Important Dates
The next estimated earnings date is Wednesday, August 7, 2024, after market close.
| Earnings Date | Aug 7, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
BioCardia has 1.82 million shares outstanding. The number of shares has increased by 24.56% in one year.
| Shares Outstanding | 1.82M |
| Shares Change (YoY) | +24.56% |
| Shares Change (QoQ) | +11.57% |
| Owned by Insiders (%) | 29.56% |
| Owned by Institutions (%) | 7.13% |
| Float | 1.21M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 11.32 |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 11.91 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.31
| Current Ratio | 0.31 |
| Quick Ratio | 0.25 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -261.70% |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | $23,400 |
| Profits Per Employee | -$516,850 |
| Employee Count | 20 |
| Asset Turnover | 0.12 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -91.42% in the last 52 weeks. The beta is 1.37, so BioCardia's price volatility has been higher than the market average.
| Beta (5Y) | 1.37 |
| 52-Week Price Change | -91.42% |
| 50-Day Moving Average | 4.09 |
| 200-Day Moving Average | 6.50 |
| Relative Strength Index (RSI) | 36.89 |
| Average Volume (20 Days) | 85,271 |
Short Selling Information
The latest short interest is 47,987, so 2.64% of the outstanding shares have been sold short.
| Short Interest | 47,987 |
| Short Previous Month | 77,130 |
| Short % of Shares Out | 2.64% |
| Short % of Float | 3.97% |
| Short Ratio (days to cover) | 0.14 |
Income Statement
In the last 12 months, BioCardia had revenue of $468,000 and -$10.34 million in losses. Loss per share was -$7.05.
| Revenue | 468,000 |
| Gross Profit | 468,000 |
| Operating Income | -10.41M |
| Pretax Income | -10.34M |
| Net Income | -10.34M |
| EBITDA | -9.92M |
| EBIT | -10.34M |
| Loss Per Share | -$7.05 |
Balance Sheet
The company has $949,000 in cash and $1.23 million in debt, giving a net cash position of -$279,000 or -$0.15 per share.
| Cash & Cash Equivalents | 949,000 |
| Total Debt | 1.23M |
| Net Cash | -279,000 |
| Net Cash Per Share | -$0.15 |
| Equity (Book Value) | -2.28M |
| Book Value Per Share | -1.25 |
| Working Capital | -2.81M |
Cash Flow
In the last 12 months, operating cash flow was -$8.94 million and capital expenditures -$2,000, giving a free cash flow of -$8.95 million.
| Operating Cash Flow | -8.94M |
| Capital Expenditures | -2,000 |
| Free Cash Flow | -8.95M |
| FCF Per Share | -$5.34 |
Margins
Gross margin is 100.00%, with operating and profit margins of -2,224.15% and -2,208.76%.
| Gross Margin | 100.00% |
| Operating Margin | -2,224.15% |
| Pretax Margin | -2,208.76% |
| Profit Margin | -2,208.76% |
| EBITDA Margin | -2,119.87% |
| EBIT Margin | -2,208.76% |
| FCF Margin | -1,911.54% |
Dividends & Yields
BioCardia does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -24.56% |
| Shareholder Yield | -24.56% |
| Earnings Yield | -195.15% |
| FCF Yield | -168.89% |
Analyst Forecast
The average price target for BioCardia is $60.00, which is 1,961.86% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $60.00 |
| Price Target Difference | 1,961.86% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on May 30, 2024. It was a reverse split with a ratio of 1:15.
| Last Split Date | May 30, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:15 |
Scores
BioCardia has an Altman Z-Score of -93.89 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -93.89 |
| Piotroski F-Score | 2 |